• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Matern Fetal Neonatal Med . Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level referenc

tetano

Editor, Senior Moderator
J Matern Fetal Neonatal Med


. 2021 Mar 26;1-5.
doi: 10.1080/14767058.2021.1902500. Online ahead of print.
Clinical characteristics and risk factors for SARS-CoV-2 infection in pregnant women attending a third level reference center in Mexico City


Rosa Gabriela Hern?ndez-Cruz[SUP] 1 [/SUP], Daniela S?nchez-Cobo[SUP] 1 [/SUP], Sandra Acevedo-Gallegos[SUP] 1 [/SUP], Addy Cecilia Helguera-Repetto[SUP] 1 [/SUP], Mario Roberto Rodriguez-Bosch[SUP] 1 [/SUP], Victor Hugo Ramirez-Santes[SUP] 1 [/SUP], Isabel Villegas-Mota[SUP] 1 [/SUP], Arturo Cardona-P?rez[SUP] 1 [/SUP], Manuel Cortes-Bonilla[SUP] 1 [/SUP], Claudine Irles[SUP] 1 [/SUP], Paloma Mateu-Rogell[SUP] 1 [/SUP], Job Villanueva-Calleja[SUP] 1 [/SUP], Oscar Villavicencio Carrisoza[SUP] 1 [/SUP], Gaudalupe Estrada-Guti?rrez[SUP] 1 [/SUP], Salvador Espino-Y-Sosa[SUP] 1 [/SUP], Johnatan Torres-Torres[SUP] 1 2 [/SUP], Raigam Jafet Martinez-Portilla[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: COVID-19 symptoms vary widely among pregnant women. We aimed to assess the most frequent symptoms amongst pregnant women with SARS-CoV-2 infection in a tertiary hospital in Mexico City.
Methods: A cross-sectional study of pregnant women attending the National Institute of Perinatology in Mexico City was performed. All women who attended the hospital, despite their symptoms, were tested for SARS-CoV-2. A multivariate-age-adjusted logistic regression was used to assess the association between the main outcome and each characteristic of the clinical history.
Results: A total of 1880 women were included in the data analysis. Among all women, 30.74% (n = 578) had a positive PCR for SARS-CoV-2 from which 2.7 (n = 50) were symptomatic. Symptoms associated with a positive PCR result were headache (p=.01), dyspnea (p=.043), and myalgia (p=.043).
Conclusions: At universal screening for SARS-CoV-2, one-third of the population had a positive result, while those symptoms associated with a positive PCR were headache, dyspnea, and myalgia.

Keywords: COVID-19; SARS-CoV-2; coronavirus 2019; pregnancy; universal screening.
 
Back
Top Bottom